ABT » Topics » All Other Compensation.

This excerpt taken from the ABT DEF 14A filed Mar 16, 2009.

Other Compensation

    Non-business related flights on corporate aircraft are covered by time-sharing lease agreements, pursuant to which certain costs associated with those flights are reimbursed in accordance with Federal Aviation Administration regulations. Messrs. White and Freyman have such agreements and reimbursed Abbott for non-business flights in accordance with those agreements.


19

      The following amounts are included in the totals in this column, which reflect Abbott's incremental cost less reimbursements for non-business related flights, M. D. White: $139,683 / $103,292 / $90,154; and T. C. Freyman: $1,138 / $0 / $8,148.

      Abbott determines the incremental cost for these flights based on the direct cost to Abbott, including fuel costs, parking, handling and landing fees, catering, travel fees, and other miscellaneous direct costs.

      Included in the totals shown in this column for 2008 are costs associated with security: M. D. White: $180,467; T. C. Freyman: $38,309; and L. J. Schumacher: $10,697. Abbott determines the cost for these expenses based on its actual costs. The security is provided on the recommendation of an independent security study.

      Also included in the totals shown in the table is the cost of providing a corporate automobile less the amount reimbursed by the executive: M. D. White: $0 / $7,344 / $6,137; T. C. Freyman: $10,654 / $7,364 / $7,370; J. M. Capek: $10,331; L. J. Schumacher: $21,093; and J. L. Tyree: $18,471 / $20,337.

      For J. M. Capek, L. J. Schumacher, and J. L. Tyree, costs associated with financial planning are included: J. M. Capek: $2,680; L. J. Schumacher: $10,000; and J. L. Tyree: $4,500 / $3,000.

      For J. M. Capek, a payment of $936,938 made pursuant to an agreement entered following Abbott's acquisition in 2006 of the vascular intervention and endovascular solutions businesses of Guidant Corporation in exchange for the release of certain rights and obligations under the Guidant Change in Control Severance Pay Plan for Select Employees and contingent upon continued employment is included. Also included are relocation expenses of $10,000.

      The named officers are also eligible to participate in an executive disability benefit described on page 34.


20


This excerpt taken from the ABT DEF 14A filed Mar 19, 2008.

Other Compensation

    Non-business related flights on corporate aircraft are covered by time-sharing lease agreements, pursuant to which certain costs associated with those flights are reimbursed in accordance with Federal Aviation Administration regulations. Messrs. White and Freyman have such agreements and reimbursed Abbott for non-business flights in accordance with those agreements.

    The following amounts are included in the totals in this column, which reflect Abbott's incremental cost less reimbursements for non-business related flights, M. D. White: $103,292 / $90,154; T. C. Freyman: $0 / $8,148; and R. A. Gonzalez: $54,766 / $43,546.

    Abbott determines the incremental cost for these flights based on the direct cost to Abbott, including fuel costs, parking, handling and landing fees, catering, travel fees, and other miscellaneous direct costs.

    Also included in the totals shown in the table is the cost of providing a corporate automobile less the amount reimbursed by the executive:

    M. D. White: $7,344 / $6,137; T. C. Freyman: $7,364 / $7,370; H. A. Liepmann: $22,407 / $22,561; J. L. Tyree: 20,337; S. R. Fussell: $19,145; R. A. Gonzalez: $18,604 / $23,426; and, W. G. Dempsey: $4,094 / $15,884.

    For Messrs. Liepmann, Tyree, Fussell, Gonzalez, and Dempsey costs associated with financial planning are included: H. A. Liepmann, $8,000 / $10,000; J. L. Tyree, $3,000; S. R. Fussell: $10,000; R. A. Gonzalez: $10,000 / $7,500; and, W. G. Dempsey: $10,000 / $10,000.

    The named officers are also eligible to participate in an executive disability benefit described on page 36.

    For Mr. Liepmann, incremental tax payments of $75,127 in 2006 resulting from his multi-year assignment outside the United States are included.

(7)
Effective September 30, 2007, R. A. Gonzalez retired as President and Chief Operating Officer and as a member of Abbott's Board of Directors.

(8)
Effective August 31, 2007, W. G. Dempsey retired as Executive Vice President, Pharmaceutical Products Group. With his retirement, he forfeited 13,333 restricted shares granted in 2006 and 14,000 restricted shares granted in 2007.

19


This excerpt taken from the ABT DEF 14A filed Mar 19, 2007.

All Other Compensation.

M. D. White: $96,291; R. A. Gonzalez: $74,472; T. C. Freyman: $15,518; W. G. Dempsey: $25,884; H. Liepmann: $107,688; and J. M. Leiden: $38,740.

    Non-business related flights on corporate aircraft are covered by time-sharing lease agreements, pursuant to which certain costs associated with those flights are reimbursed in accordance with Federal Aviation Administration regulations. Messrs. Gonzalez, Freyman, and White have such agreements and reimbursed the Company for non-business flights in accordance with those agreements.

    Included in All Other Compensation are the following amounts, which reflect Abbott's incremental cost less reimbursements for non-business related flights: M. D. White, $90,154; R. A. Gonzalez, $43,546; T. C. Freyman, $8,148; and, J. M. Leiden $11,235. The company determines the incremental cost for these flights based on the direct cost to Abbott, including fuel costs, parking, handling and landing fees, catering, travel fees, and other miscellaneous direct costs.

    Also included in All Other Compensation is the cost of providing a corporate automobile less amount reimbursed by the executive: M. D. White, $6,137; R. A. Gonzalez, $23,426; T. C. Freyman, $7,370; W. G. Dempsey, $15,884; H. Liepmann, $22,561; and, J. M. Leiden, $17,505.

    For Messrs. Gonzalez, Dempsey, Liepmann, and Dr. Leiden, costs associated with financial planning are included: R. A. Gonzalez, $7,500; W. G. Dempsey, $10,000; H. Liepmann, $10,000; and, J. M. Leiden, $10,000.

    For Mr. Liepmann, incremental tax payments of $75,127 resulting from his multi-year assignment outside the United States are included.

    The named officers are also eligible to participate in an executive disability benefit described on page 15.

(6)
The amount of salary and bonus (including performance-based bonuses described in footnote 3, above) in relation to total compensation is as follows: M. D. White: 21.2%; R. A. Gonzalez: 15.0%; T. C. Freyman: 31.6%; W. G. Dempsey: 25.3%; H. Liepmann: 22.6%; and J. M. Leiden: 4.7%.

(7)
Effective March 24, 2006, Dr. Jeffrey M. Leiden stepped down as a director and as president and chief operating officer of Abbott's Pharmaceutical Products Group.


18


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki